TWI453046B - Diabetes system of hyperglycemia - Google Patents
Diabetes system of hyperglycemia Download PDFInfo
- Publication number
- TWI453046B TWI453046B TW101114982A TW101114982A TWI453046B TW I453046 B TWI453046 B TW I453046B TW 101114982 A TW101114982 A TW 101114982A TW 101114982 A TW101114982 A TW 101114982A TW I453046 B TWI453046 B TW I453046B
- Authority
- TW
- Taiwan
- Prior art keywords
- frequency
- period
- control
- modulation period
- decreasing
- Prior art date
Links
Landscapes
- Electrotherapy Devices (AREA)
Description
本發明係有關於一種糖尿病高血糖因子的舒緩系統,尤指一種利用調變頻段做為治療糖尿病高血糖因子的電能波配方技術。The invention relates to a soothing system for diabetic hyperglycemic factors, in particular to an electric energy wave formulating technique using a modulated frequency band as a therapeutic high blood sugar factor for diabetes.
糖尿病是一種嚴重性的新陳代謝疾病。當人體內的胰島素分泌不足時,葡萄糖則無法進入細胞內被利用,致使血液中的葡萄糖含量增加,以致引起內分泌的代謝失調。根據美國糖尿病協會的推薦標準,滿足以下任一條件,即可診斷為糖尿病:1.空腹血漿血糖在7.0毫摩爾/升(126毫克/分升)或以上;2.在口服糖耐量試驗中,口服75克葡萄糖2小時後,血漿血糖在11.1毫摩爾/升(200毫克/分升)或以上;3.有高血糖病徵,並且隨機血漿血糖在11.1毫摩爾/升(200毫克/分升)或以上;及4.糖化血紅蛋白(HbA1C)在6.5或以上。倘若人體血糖過高,葡萄糖則無法完全被腎臟所吸收,以致葡萄糖會隨著尿液排出,當尿液含有大量的糖分時,則是所謂的糖尿病。目前西醫用於治療糖尿病的方法大致有二種,第一種是以注射方式補充胰島素。第二種則是以口服藥物的方式來控制血糖。雖然上述治療方法皆可促進胰島素的分泌或是降低胰島素的抗性,藉以控制病患的糖尿病之高血糖因子,惟,上述治療方法僅能控制糖尿病的血糖而無法根治,倘若停止注射胰島素或口服藥物治療時,則會引發諸多的併發症出現,不僅如此,上述治療方法為一種侵入式的對抗療法,因此,在長期治療之下,較容易傷及腎臟,終致造成洗腎的憾事。Diabetes is a serious metabolic disease. When the insulin secretion in the human body is insufficient, glucose can not be used into the cells, resulting in an increase in the amount of glucose in the blood, resulting in endocrine metabolic disorders. Diabetes can be diagnosed according to the following criteria of the American Diabetes Association: 1. Fasting plasma glucose is 7.0 mmol/L (126 mg/dl) or above; 2. In the oral glucose tolerance test, After 2 hours of oral administration of 75 grams of glucose, plasma blood glucose was 11.1 mmol/L (200 mg/dl) or more; 3. Hyperglycemia was present, and random plasma glucose was 11.1 mmol/L (200 mg/dl) Or above; and 4. Glycated hemoglobin (HbA1C) is 6.5 or above. If the body's blood sugar is too high, glucose can not be completely absorbed by the kidneys, so that glucose will be discharged with the urine. When the urine contains a lot of sugar, it is called diabetes. At present, there are two methods for Western medicine to treat diabetes. The first one is to supplement insulin by injection. The second is to control blood sugar by means of oral medication. Although the above treatment methods can promote the secretion of insulin or reduce the resistance of insulin, thereby controlling the hyperglycemic factor of diabetes in patients, the above treatment can only control the blood sugar of diabetes and cannot cure, if the injection of insulin or oral administration is stopped. In the case of drug treatment, many complications will occur. Not only that, but the above treatment method is an invasive anti-therapeutic treatment. Therefore, under long-term treatment, it is more likely to cause damage to the kidneys, resulting in regrets of dialysis.
至於中醫治療糖尿病的方面,如中華民國發明第I356706『可控制代謝症候群之中草藥組成物』專利所示,其係由咸豐草與人蔘組成,具有促進胰島素分泌與降低胰島素抗性的作用,雖然該習用治療方法可以調節人體血糖值,惟,其仍然是屬於口服藥物治療的一種,故可將其視為廣義的間接侵入性治療,因為其所發揮出的藥性仍會對人體產生約束(Chemical Restraint)作用,因此,在長期服用治療之下,同樣容易傷及腎臟器官。As for the treatment of diabetes by Chinese medicine, as shown in the patent of the Republic of China Invention No. I356706 "Controllable metabolic syndrome Chinese herbal medicine composition", it is composed of Xianfeng grass and human mites, which has the effect of promoting insulin secretion and reducing insulin resistance, although The conventional treatment method can regulate the blood sugar level of the human body, but it is still a kind of oral drug treatment, so it can be regarded as a generalized indirect invasive treatment because the drug exerted by it still has a constraint on the human body (Chemical Restraint), therefore, it is also easy to damage kidney organs under long-term treatment.
再者,根據量子醫學的理論認為,一切生物、生命體皆具各自的生理頻率(即生物共振波),人體健康時,體內則會展現出協調統一的波動頻率。反之,當人體展現出波動頻率失調時,則表示該生物受到機能退化、疾病或是病毒的諧波干擾而呈病態。1930年代美國物理學家Royal Rife發現每一個物體包含細菌、病毒都擁有各自的自然頻率。該發現於1934年經過南加州大學的醫師們以實例進行診療試驗,獲得令人滿意的成效。Royal Rife的研究發現不同的共振波頻率對人體有不同的生理反應,據此加拿大商共振光公司乃針對人體生理頻率而研發出一種共振波人體保健儀。該儀器所發射之電能波的波長介於4~20微米(um),與人體生物波3~45微米(um)的波長接近,而具有人體保健功能。目前更有許多利用電磁波治療癌症的研究興盛。雖然習知技術已經知道可將電能波導入人體,以與人體之生理頻率產生共振而達到治療功能。然而,對於治療糖尿病而言,目前習知的技術或研究,尚未有利用電能波技術來完整地建構出一套可以有效減除糖尿病高血糖因子之調變頻段的治療配方。Furthermore, according to the theory of quantum medicine, all living organisms and living organisms have their own physiological frequencies (ie, biological resonance waves). When the human body is healthy, the body will exhibit a coordinated and uniform fluctuation frequency. Conversely, when the human body exhibits a wave frequency misalignment, it indicates that the organism is pathologically affected by functional deterioration, disease, or virus harmonic interference. In the 1930s, American physicist Royal Rife discovered that every object contains bacteria and viruses that have their own natural frequencies. The findings were tested in 1934 by physicians at the University of Southern California with examples and achieved satisfactory results. The Royal Rife study found that different resonant wave frequencies have different physiological responses to the human body. According to this, the Canadian Resonance Light Company has developed a resonant wave human health instrument for human physiological frequency. The energy wave emitted by the instrument has a wavelength of 4 to 20 micrometers (um), which is close to the wavelength of human biological waves of 3 to 45 micrometers (um), and has a human health function. There are many studies that use electromagnetic waves to treat cancer. Although it is known in the prior art that electrical energy waves can be introduced into the human body to resonate with the physiological frequency of the human body to achieve a therapeutic function. However, for the treatment of diabetes, the current techniques or research have not yet utilized the energy wave technology to completely construct a therapeutic formula that can effectively reduce the modulation frequency band of diabetic hyperglycemic factors.
因鑑於生物共振波對於人體疾病的治療有極大的可能療效,而習知技術中尚未有一套應用於減除糖尿病高血糖因子的電能波配方,本發明人等乃積極努力研發,經實作與實驗,終而研發出可以改善糖尿病的電能波配方。本發明所達成之功效,於上述習用結構均無法有效具體達成,為確保本發明之合法權益,爰依法具文提出專利申請。Since the bioresonance wave has a great potential therapeutic effect on the treatment of human diseases, and the conventional technology does not have a set of electric energy wave formulas for reducing diabetes high blood sugar factor, the inventors actively work hard to develop, and practice Experiments have led to the development of an energy wave formula that can improve diabetes. The effects achieved by the present invention cannot be effectively and specifically achieved in the above-mentioned conventional structures. To ensure the legal rights and interests of the present invention, a patent application is filed according to law.
本發明主要目的,在於提供一種糖尿病高血糖因子的舒緩系統,主要是以頻段調變之電能波來做為減除糖尿病高血糖因子的配方,經臨床實驗例證實,依據頻段調變所控制產生的電能波,確實可以有效減除糖尿病的高血糖因子,並可讓糖血色素下降,藉以促進胰島素分泌以及降低胰島素的抗性作用。達成本發明發明目的之技術手段,係設計一包括有電能波產生器的系統,於電能波產生器設定有用以控制產生電能波之頻率作用時段控制配方。頻率作用時段控制配方包括有至少一個單頻作用時段之控制及至少一個多頻調變作用時段之控制。電能波產生器於作用時程中依據所設計的頻率作用時段控制配方對一患有糖尿病的人體在單頻作用時段中控制發射單一頻率之電能波及在多頻調變作用時段中控制發射多個頻段之電能波,藉由電能波減除人體之糖尿病的高血糖因子(例如血糖、糖化血色素)。The main object of the present invention is to provide a soothing system for diabetic hyperglycemic factors, which is mainly characterized by a power wave modulated by a frequency band as a formula for reducing diabetes high blood glucose factor, which is controlled by clinical experiments and controlled according to frequency band modulation. The electric energy wave can effectively reduce the high blood sugar factor of diabetes, and can reduce the hemoglobin, thereby promoting insulin secretion and reducing the resistance of insulin. A technical means for achieving the object of the present invention is to design a system including an energy wave generator for setting a frequency control period control recipe useful for controlling the generation of electric energy waves. The frequency action period control recipe includes control of at least one single frequency action period and control of at least one multi-frequency modulation period. The power wave generator controls the formula in a time course of the action according to the designed frequency action period to control the emission of a single frequency energy wave in a single frequency action period and control the emission in the multi-frequency modulation period during a single frequency action period The energy wave of the frequency band is used to reduce the high blood sugar factor (such as blood sugar and glycated hemoglobin) of the human body by the electric energy wave.
請參看圖1~3所示,達成本發明目的之基本技術特徵,係設計一包括有電能波產生器的系統,於電能波產生器設定有用以控制產生電能波之頻率作用時段控制配方,以電能波產生器10對患有糖尿病的人體於一作用時程中發射電能波。頻率作用時段控制配方包括有至少一個單頻作用時段之控制及至少一個多頻調變作用時段之控制。電能波產生器於作用時程中依據所設計的頻率作用時段控制配方對一患有糖尿病的人體在單頻作用時段中控制發射單一頻率之電能波及在多頻調變作用時段中控制發射多個頻段之電能波,藉由電能波減除人體之糖尿病的高血糖因子(例如血糖、糖化血色素)。Referring to FIGS. 1 to 3, the basic technical features of the object of the present invention are to design a system including an energy wave generator, and set a frequency action period control formula useful for controlling the generation of the energy wave in the energy wave generator. The power wave generator 10 emits an electric energy wave to a human body suffering from diabetes in a time course of action. The frequency action period control recipe includes control of at least one single frequency action period and control of at least one multi-frequency modulation period. The power wave generator controls the formula in a time course of the action according to the designed frequency action period to control the emission of a single frequency energy wave in a single frequency action period and control the emission in the multi-frequency modulation period during a single frequency action period The energy wave of the frequency band is used to reduce the high blood sugar factor (such as blood sugar and glycated hemoglobin) of the human body by the electric energy wave.
為了能設定電能波之頻率作用時段控制配方,及能依據所設計的頻率作用時段控制配方對一患有糖尿病的人體在單頻作用時段中控制發射單一頻率之電能波及在多頻調變作用時段中控制發射多個頻段之電能波。如圖1、3所示,本發明系統之電能波產生器10係包含一操作界面11、一控制驅動單元12、一用以儲存電能波之頻譜資料的資料庫13及一電能波發射單元14。操作界面11可供使用者操作而啟動或關閉電能波產生器10。控制驅動單元12可受操作界面11的觸發而讀取資料庫13中的頻譜資料,並輸出一用以控制電能波發射單元14通、斷的驅動指令訊號,使電能波發射單元14發射出與該頻譜資料相應的電能波。電能波發射單元14則可依據該驅動指令訊號於該時段內對該人體發射電能波。圖1所示 之電能波發射單元14係為一種可以發出特定頻率之電磁波的發射器,而可將電磁波向外發射出去。除此之外,電能波發射單元14也可以是一種發出特定頻率之光波的光波發射器;或是可以發出特定頻率之聲波的音頻放大器與揚聲器的組合。再者,必須說明的是,本發明亦可採用市售的電能波產生器,僅需控制電能波的發射時間,並對各時段進行頻段的調變作動,同樣可以作為改善糖尿病高血糖因子的配方。In order to be able to set the frequency action period control formula of the electric energy wave, and according to the designed frequency action period control formula, the control unit can control the emission of a single frequency energy wave in a single frequency action period in a multi-frequency modulation period Controls the transmission of energy waves in multiple frequency bands. As shown in FIG. 1 and FIG. 3, the power wave generator 10 of the system of the present invention comprises an operation interface 11, a control driving unit 12, a data library 13 for storing spectral data of electric energy waves, and an energy wave transmitting unit 14. . The operation interface 11 is operable by a user to activate or deactivate the power wave generator 10. The control driving unit 12 can read the spectrum data in the data library 13 by the trigger of the operation interface 11, and output a driving command signal for controlling the power wave transmitting unit 14 to be turned on and off, so that the energy wave transmitting unit 14 emits The spectral data corresponds to the energy wave. The power wave transmitting unit 14 can emit an electric energy wave to the human body according to the driving command signal during the period. Figure 1 shows The power wave transmitting unit 14 is a transmitter that can emit electromagnetic waves of a specific frequency, and the electromagnetic waves can be emitted outward. In addition, the power wave emitting unit 14 may be a light wave transmitter that emits light waves of a specific frequency; or a combination of an audio amplifier and a speaker that can emit sound waves of a specific frequency. Furthermore, it must be noted that the present invention can also adopt a commercially available electric energy wave generator, which only needs to control the emission time of the electric energy wave, and adjusts the frequency band in each time period, and can also be used as an improvement for diabetic hyperglycemic factors. formula.
3.1本發明電能波之頻率作用時段控制配方3.1 The frequency action period control formula of the electric energy wave of the invention
本發明實驗例中,電能波的波形為矩形,每一工作周期(Duty cycle)中電能波之發射率為70%,亦即,70%部分為正電位的方波輸出,另外30%的部分則為關閉狀態的0電位。單頻作用時段與多頻調變作用時段的時間相對於整個作用時程的時間比例分別約為42.39%及57.61%。至少一個單頻作用時段之控制為複數個,其各控制之電能波的頻率分別不同。本發明電能波之頻率作用時段控制配方,在其基本的變頻機制原則下,自整個作用時程起始至結束,其頻率可以逐漸減小(如圖4所示),亦可逐漸增大(如圖5所示),且在本實驗例中自該作用時程起始至結束,其頻率是依序逐漸減小。至少一個多頻調變作用時段之控制為複數個,且選自漸減調變時段之控制、漸增調變時段之控制及增減交錯調變時段之控制至少其中一種,漸減調變時段之控制係於漸減調變時段中控制電能波於一預定頻寬內做頻率漸減的分佈,漸增調變時段之控 制係於漸增調變時段中控制該電能波於一預定頻寬內做頻率漸增的分佈,增減交錯調變時段之控制係於增減交錯調變時段中控制電能波於一預定頻寬內做漸增頻率與漸減頻率的一增與一減的交錯分佈。多頻調變作用時段中之漸減調變時段、漸增調變時段及增減交錯調變時段所佔該時段的時間比例分別約為30.23%、43.91%及25.86%。漸減調變時段中所控制的每兩相鄰頻率值差1Hz。漸增調變時段中所控制的每兩相鄰頻率值差1Hz。增減交錯調變時段中所控制的每兩相鄰漸增頻率值及每兩相鄰漸減頻率值分別差1Hz。漸減調變時段之控制中的該預定頻寬為3Hz。漸增調變時段之控制中的該預定頻寬為9Hz。增減交錯調變時段之控制中的該預定頻寬為9Hz。In the experimental example of the present invention, the waveform of the electric energy wave is rectangular, and the emissivity of the electric energy wave in each duty cycle is 70%, that is, 70% is a square wave output of a positive potential, and another 30% is part. It is the zero potential of the off state. The time ratios of the single-frequency action period and the multi-frequency modulation period to the entire duration of the action are approximately 42.39% and 57.61%, respectively. The control of at least one single frequency action period is a plurality of, and the frequency of each controlled power wave is different. The frequency action period control formula of the electric energy wave of the invention, under the principle of the basic frequency conversion mechanism, the frequency can be gradually reduced from the beginning to the end of the whole action time course (as shown in FIG. 4), and can also be gradually increased ( As shown in FIG. 5, and in the present experimental example, the frequency is gradually decreased from the beginning to the end of the action time course. The control of the at least one multi-frequency modulation period is plural, and is selected from the control of the decreasing modulation period, the control of the increasing modulation period, and the control of increasing or decreasing the interleaving period, and controlling the decreasing period Controlling the distribution of the power wave in a decreasing frequency during a decreasing modulation period, and gradually controlling the frequency of the modulation period The system controls the distribution of the power wave in a predetermined frequency width in an increasing frequency modulation period, and the control of increasing or decreasing the interleaving modulation period controls the power wave at a predetermined frequency in the increasing and decreasing interleaving modulation period. The width of the increasing frequency and the decreasing frequency are increased and decreased. During the multi-frequency modulation period, the decreasing proportion of the modulation period, the increasing modulation period, and the increasing or decreasing interleaving period accounted for about 30.23%, 43.91% and 25.86%, respectively. The difference between each two adjacent frequency values controlled in the decreasing modulation period is 1 Hz. The difference between each two adjacent frequency values controlled in the increasing modulation period is 1 Hz. Each of the two adjacent increasing frequency values and each two adjacent decreasing frequency values controlled in the increasing or decreasing interleaving modulation period are respectively different by 1 Hz. The predetermined bandwidth in the control of the decreasing modulation period is 3 Hz. The predetermined bandwidth in the control of the increasing modulation period is 9 Hz. The predetermined bandwidth in the control of increasing or decreasing the interleaving modulation period is 9 Hz.
如圖4至6及附件圖表所示,本發明單頻作用時段之控制於表中顯示為”Single Frequency”,漸減調變時段之控制於表中顯示為”Sweep Decreasing”,漸增調變時段之控制於表中顯示為”Sweep Increasing”,增減交錯調變時段之控制於表中顯示為”Spread Contract”。As shown in FIG. 4 to FIG. 6 and the attached diagram, the control of the single-frequency action period of the present invention is shown as “Single Frequency” in the table, and the control of the decreasing and decreasing modulation period is displayed as “Sweep Decreasing” in the table, and the modulation period is gradually increased. The control is shown in the table as "Sweep Increasing", and the control of increasing or decreasing the interleaving modulation period is shown as "Spread Contract" in the table.
於漸減調變時段之控制中,第一頻率範圍值於各時段(Level)設定有不同的基本頻率(Base)與頻寬(Width),該第一頻率範圍值第一個輸出頻率為該頻寬與該基本頻率的相加,第二個輸出頻率為將該第一個輸出頻率減去一調變量(如1Hz),當下一個輸出頻率等於該基本頻率時,該下一個頻率則為最後一個輸出頻率。舉例說明,假設基本頻率為100Hz,頻寬(Width)為3Hz,該時段(Level) 的每一個頻率的發射時間為3秒,依據上式可求得頻率數(freqs)為4個,頻率輸出的順序分別為103Hz、102Hz、101Hz及100Hz,該時段總共的發射時間累計為3*(3+1)=12秒。In the control of the decreasing modulation period, the first frequency range value is set with different basic frequency (Base) and bandwidth (Width) in each period (Level), and the first frequency range value is the first output frequency is the frequency The width is added to the fundamental frequency, and the second output frequency is the first output frequency minus a modulation variable (such as 1 Hz). When the next output frequency is equal to the basic frequency, the next frequency is the last one. Output frequency. For example, assume that the fundamental frequency is 100 Hz and the bandwidth is 3 Hz. The transmission time of each frequency is 3 seconds. According to the above formula, the number of frequencies (freqs) can be determined as 4, and the order of frequency output is 103Hz, 102Hz, 101Hz and 100Hz respectively. The total transmission time of this period is 3*. (3+1) = 12 seconds.
於漸增調變時段之控制中,第二頻率範圍值於各時段(Level)設定有不同的基本頻率(Base)與頻寬(Width),該第二頻率範圍值第一個輸出頻率為該基本頻率,第二個輸出頻率為將該第一個輸出頻率加上一調變量(如1Hz),當下一個輸出頻率等於該基本頻率與該頻寬的總合時,該下一個頻率則為最後一個輸出頻率。舉例說明,假設基本頻率為100Hz,頻寬為3Hz,該時段的每一個頻率的發射時間為3秒,依據上式可求得頻率數為4個,頻率輸出的順序分別為100Hz、101Hz、102Hz及103Hz,該時段總共的發射時間累計為3*(3+1)=12秒。In the control of the increasing modulation period, the second frequency range value is set with different basic frequency (Base) and bandwidth (Width) in each period (Level), and the first output frequency of the second frequency range value is The basic frequency, the second output frequency is the first output frequency plus a modulation variable (such as 1 Hz), when the next output frequency is equal to the sum of the fundamental frequency and the bandwidth, the next frequency is the last An output frequency. For example, suppose the basic frequency is 100 Hz, the bandwidth is 3 Hz, and the transmission time of each frequency in this period is 3 seconds. According to the above formula, the number of frequencies can be determined as four, and the order of frequency output is 100 Hz, 101 Hz, and 102 Hz, respectively. And 103 Hz, the total transmission time of this period is accumulated to be 3*(3+1)=12 seconds.
於增減交錯調變時段之控制中,第三頻率範圍值於各時段(Level)設定有不同的基本頻率(Base)與頻寬(Width),該第三頻率範圍值第一個輸出頻率為該頻寬與基本頻率的總合,第二個輸出頻率為將該頻寬與該基本頻率相減,再將該第一個頻率減一調變量(如1Hz)而成為第三個輸出頻率,另將該第二個頻率減去該調變量而成為第四個輸出頻率,當下一個該頻率等於該基本頻率時,下一個該頻率則為最後一個輸出頻率。舉例說明,假設基本頻率為100Hz,頻寬為3Hz,該時段的每一個頻率的發射時間為3秒,依據上式可求得頻率數為7個,頻率輸出的順序分別為103Hz、97Hz、102Hz、98Hz、101Hz、99Hz及100Hz,該時段總共的發射時間累計 為3*(2*3+1)=21秒。In the control of increasing or decreasing the interleaving modulation period, the third frequency range value is set with different basic frequency (Base) and bandwidth (Width) in each period (Level), and the first output frequency of the third frequency range value is The sum of the bandwidth and the fundamental frequency, the second output frequency is the subtraction of the bandwidth from the fundamental frequency, and then the first frequency is decremented by a variable (eg, 1 Hz) to become the third output frequency. The second frequency is further subtracted from the modulation variable to become the fourth output frequency. When the next frequency is equal to the fundamental frequency, the next frequency is the last output frequency. For example, suppose the basic frequency is 100 Hz and the bandwidth is 3 Hz. The transmission time of each frequency in this period is 3 seconds. According to the above formula, the number of frequencies can be determined as 7 and the order of frequency output is 103 Hz, 97 Hz, and 102 Hz, respectively. , 98Hz, 101Hz, 99Hz and 100Hz, the total transmission time accumulated in this period It is 3*(2*3+1)=21 seconds.
此外,如附件圖表所示,漸減調變時段之控制的頻寬介於1~3Hz之間,其輸出之頻率數量介於2~4個之間。漸增調變時段之控制的頻寬介於2~9Hz之間,其輸出之頻率數量介於3~10個之間。增減交錯調變時段之控制的頻寬介於5~9Hz之間,其輸出之頻率數量介於11~19個之間。In addition, as shown in the attached chart, the control of the decreasing modulation period is between 1 and 3 Hz, and the output frequency is between 2 and 4. The bandwidth of the control of the increasing modulation period is between 2 and 9 Hz, and the frequency of the output is between 3 and 10. The bandwidth of the control of increasing or decreasing the interleaving modulation period is between 5 and 9 Hz, and the frequency of the output is between 11 and 19.
3.2.本發明的實驗操作3.2. Experimental operation of the present invention
經由臨床實驗中得知,本發明於每日最後一餐後的60分鐘為治療糖尿病的較佳時機。每一次的作用時間(即治療的時間)約為44分鐘21秒左右,劃分為50個時段,且於50個時段中,電能波的波形皆為正電位的方波,每一工作周期(Duty cycle)的正電位方波發射率皆在70%左右,換言之,在base的頻率之波形一個周期內,具有70%時間的正能量(high Voltage),而其餘30%時間為負能量(0 Voltage),或可以定義,在一個pulse rate周期(發送頻率之ON/OFF周期)裡(附件圖表所示的Pulse Rate為1Hz),有70%的時間有發送頻率(ON),30%的時間無發送頻率(OFF)。一個療程持續20~40天左右,得以獲得初步的改善。如圖1所示,當欲對糖尿病患者進行電能波的能量治療時,啟動電能波產生器10,電能波發射單元14受驅動指令訊號的驅動而依據電能波之頻率作用時段控制配方發射出電能波。It is known from clinical trials that the present invention is a preferred time to treat diabetes at 60 minutes after the last meal of the day. Each action time (ie, treatment time) is about 44 minutes and 21 seconds, divided into 50 time periods, and in 50 time periods, the waveforms of the energy waves are positive square waves, each duty cycle (Duty The positive-potential square wave emissivity of cycle is about 70%. In other words, in the period of the frequency of the base frequency, there is 70% of the high voltage, and the remaining 30% is the negative energy (0 Voltage ), or can be defined, in a pulse rate cycle (ON/OFF cycle of the transmission frequency) (Pulse Rate shown in the attached chart is 1Hz), 70% of the time has a transmission frequency (ON), 30% of the time is not Send frequency (OFF). A course of treatment lasts for about 20 to 40 days, and a preliminary improvement can be obtained. As shown in FIG. 1 , when the energy treatment of the electric energy wave is to be performed on the diabetic patient, the electric energy wave generator 10 is activated, and the electric energy wave transmitting unit 14 is driven by the driving command signal to control the formula to emit electric energy according to the frequency action period of the electric energy wave. wave.
如圖4及附件圖表所示,本發明實驗例的作用時程中,起始的頻率為18122Hz,而逐漸調降至最終的1.2Hz。如附件圖表中得知, 開始有六個單頻作用時段,亦即電能波在第1~6時段(Level)的頻率形式為單頻作用時段之控制(Single Frequency),各時段頻率不同且依序逐漸遞減,圖表中顯示分別自18122Hz依不同時段而依序調降至3672Hz左右,單頻作用時段的時間依序分別為7秒、15秒、19秒、24秒、26秒及28秒。電能波在第7時段的頻率形式為漸減調變時段之控制(Sweep Decreasing),基本頻率值為3175Hz,頻寬值為2Hz,頻率數量為3,治療時間為10秒*3=30秒。電能波在第8時段的頻率形式為單頻作用時段之控制(Single Frequency),頻率為300Hz,治療時間分別為31秒。電能波在第9時段的頻率形式為漸減調變時段之控制(Sweep Decreasing),基本頻率值介於2127Hz,頻寬值為1Hz,頻率數為2,治療時間分別為18秒*2=36秒。電能波在第10時段的頻率形式為單頻作用時段之控制(Single Frequency),頻率為2112Hz,治療時間為35秒。電能波在第11的頻率形式時段為增減交錯調變時段之控制(Spread Contract),基本頻率為2007Hz,頻寬為7Hz,頻率數為15,治療時間分別為2秒*15=30秒。電能波在第12~17的頻率形式時段為單頻作用時段之控制(Single Frequency),頻率分別自1865Hz逐漸降至1000Hz,治療時間分別為37秒、37秒、39秒、42秒、44秒及45秒。電能波在第18時段的頻率形式為漸增調變時段之控制(Sweep Increasing),基本頻率為921Hz,頻寬為2Hz,頻率數為3,治療時間分別為15秒*3=45秒。電能波在第19時段的頻率形式為單頻作用時段之控制(Single Frequency),頻率為880Hz,治 療時間分別為47秒。電能波在第20時段的頻率形式為漸減調變時段之控制(Sweep Decreasing),基本頻率為867Hz,頻寬為1Hz,頻率數為2,治療時間分別為23秒*2=46秒。電能波在第21時段的頻率形式為增減交錯調變時段之控制(Spread Contract),基本頻率為807Hz,頻寬為7Hz,頻率數為15,治療時間分別為3秒*15=45秒。電能波在第22時段的頻率形式為增減交錯調變時段之控制(Spread Contract),基本頻值為778Hz,頻寬為9Hz,頻率數為19,治療時間分別為3秒*19=57秒。電能波在第23時段的頻率形式為單頻作用時段之控制(Single Frequency),頻率為751Hz,治療時間為49秒。電能波在第24時段的頻率形式為增減交錯調變時段之控制(Spread Contract),基本頻率為730Hz,頻寬為7Hz,頻率數為15,治療時間分別為3秒*15=45秒。電能波在第25時段的頻率形式為漸減調變時段之控制(Sweep Decreasing),基本頻率為705Hz,頻寬為3Hz,頻率數為4,治療時間分別為12秒*4=48秒。電能波在第26時段的頻率形式為漸增調變時段之控制(Sweep Increasing),基本頻率為7668Hz,頻寬為8Hz,頻率數為9,治療時間分別為6秒*9=54秒。電能波在第27時段的頻率形式為增減交錯調變時段之控制(Spread Contract),基本頻率為652Hz,頻寬為5Hz,頻率數為11,治療時間分別為5秒*11=55秒。電能波在第28時段的頻率形式為漸減調變時段之控制(Sweep Decreasing),基本頻率值為625Hz,頻寬為5Hz,頻率數為6治療時間分別為9秒第54秒。第29時段的頻率形式為單頻作用時段之 控制(Single Frequency),該頻率為612Hz,治療時間為51秒。電能波在第30時段的頻率形式為漸增調變時段之控制(Sweep Increasing),基本頻率為595Hz,頻寬為5Hz,頻率數為6,治療時間分別為9秒*6=54秒。電能波在第31時段的頻率形式為增減交錯調變時段之控制(Spread Contract),基本頻率值為542Hz,頻寬為9Hz,頻率數為19,治療時間分別為3*19秒=57秒。電能波在第32時段的頻率形式為單頻作用時段之控制(Single Frequency),該頻率為522Hz,治療時間為53秒。電能波在第33段時段的頻率形式為漸增調變時段之控制(Sweep Increasing),基本頻率為484Hz,頻寬為4Hz,頻率數為5,治療時間分別為11秒*5=55秒。電能波在第34時段的頻率形式為漸減調變時段之控制(Sweep Decreasing),基本頻率為462Hz,頻寬為3Hz,頻率數為4,治療時間分別為14秒*4=56秒。電能波在第35段時段的頻率形式為漸增調變時段之控制(Sweep Increasing),基本頻率為435Hz,頻寬為9Hz,頻率數為10,治療時間分別為6秒*10=60秒。電能波在第36段時段的頻率形式為漸減調變時段之控制(Sweep Decreasing),基本頻率為421Hz,頻寬為3Hz,頻率數為4,治療時間分別為14秒*4=56秒。電能波在第37時段的頻率形式為漸增調變時段之控制(Sweep Increasing),基本頻率為380Hz,頻寬為4Hz該序列值為5,治療時間分別為12秒*5=60秒。電能波在第38時段的頻率形式為增減交錯調變時段之控制(Spread Contract),基本頻率為348Hz,頻寬為5Hz,頻率數為11,治療 時間分別為5秒*11=55秒。電能波在第39時段為漸減調變時段之控制(Sweep Decreasing),基本頻率為302Hz,頻寬為2Hz,頻率數為3,治療時間分別為20秒*3=60秒。電能波在第40時段的頻率形式為漸增調變時段之控制(Sweep Increasing),基本頻率為160Hz,頻寬為2Hz,頻率數為3,治療時間分別為23秒*3=69秒。電能波在第41時段為增減交錯調變時段之控制(Spread Contract),基本頻率為141Hz,頻寬為6Hz,頻率數為13,治療時間分別為5秒*13=65秒。電能波在第42~43時段的頻率形式為單頻作用時段之控制(Single Frequency),頻率分別自125Hz逐漸降至95Hz,治療時間分別為72秒及76秒。電能波在第44時段的頻率形式為漸減調變時段之控制(Sweep Decreasing),基本頻率為80Hz,頻寬為1Hz,頻率數為2,治療時間分別為39秒*2=78秒。電能波在第45時段的頻率形式為增減交錯調變時段之控制(Spread Contract),基本頻率為66Hz,頻寬為7Hz,頻率數為15,治療時間分別為5秒*15=75秒。電能波在第46時段的頻率形式為增減交錯調變時段之控制(Spread Contract),基本頻率為40z,頻寬為8Hz,頻率數為17,治療時間分別為5秒*17=85秒。電能波在第47時段為增減交錯調變時段之控制(Spread Contract),基本頻率為13Hz,頻寬為7Hz,頻率數為15,治療時間分別為7秒*15=105秒。電能波在第48~50時段的頻率形式為單頻作用時段之控制(Single Frequency),頻率分別自9Hz逐漸降至1.2Hz,治療時間分別為106秒、110秒及133秒。As shown in Fig. 4 and the attached graph, in the experimental time course of the experimental example of the present invention, the initial frequency was 18122 Hz, and gradually decreased to the final 1.2 Hz. As seen in the attached chart, There are six single-frequency action periods at the beginning, that is, the frequency form of the energy wave in the first to sixth periods (Level) is the single frequency action period control (Single Frequency), the frequency of each time period is different and gradually decreases, and the graph shows From 18122Hz to 1872Hz, the timing of the single-frequency action period is 7 seconds, 15 seconds, 19 seconds, 24 seconds, 26 seconds and 28 seconds, respectively. The frequency form of the electric energy wave in the seventh period is the control of the decreasing modulation period (Sweep Decreasing), the basic frequency value is 3175 Hz, the bandwidth value is 2 Hz, the frequency number is 3, and the treatment time is 10 seconds * 3 = 30 seconds. The frequency form of the electric energy wave in the eighth period is the single frequency action period (Single Frequency), the frequency is 300 Hz, and the treatment time is 31 seconds. The frequency form of the energy wave in the ninth time period is the control of the decreasing modulation period (Sweep Decreasing), the basic frequency value is 2127 Hz, the bandwidth value is 1 Hz, the frequency number is 2, and the treatment time is 18 seconds*2=36 seconds respectively. . The frequency form of the electric energy wave in the 10th time period is a single frequency action period (Single Frequency), the frequency is 2112 Hz, and the treatment time is 35 seconds. The energy wave is in the 11th frequency form period as the control of the increase and decrease interleaving modulation period (Spread Contract), the basic frequency is 2007Hz, the bandwidth is 7Hz, the frequency is 15, and the treatment time is 2 seconds*15=30 seconds. The frequency of the energy wave in the period of the 12th to 17th is the single frequency action period (Single Frequency), the frequency is gradually reduced from 1865Hz to 1000Hz, and the treatment time is 37 seconds, 37 seconds, 39 seconds, 42 seconds, 44 seconds respectively. And 45 seconds. The frequency form of the energy wave in the 18th period is the control of the increasing modulation period (Sweep Increasing), the basic frequency is 921 Hz, the bandwidth is 2 Hz, the frequency is 3, and the treatment time is 15 seconds * 3 = 45 seconds, respectively. The frequency form of the electric energy wave in the 19th period is the single frequency action period (Single Frequency), and the frequency is 880 Hz. The treatment time is 47 seconds. The frequency form of the electric energy wave in the 20th period is the control of the decreasing modulation period (Sweep Decreasing), the basic frequency is 867 Hz, the bandwidth is 1 Hz, the frequency is 2, and the treatment time is 23 seconds*2=46 seconds, respectively. The frequency form of the energy wave in the 21st period is the control of the increase and decrease of the interleaving modulation period. The basic frequency is 807 Hz, the bandwidth is 7 Hz, the frequency is 15, and the treatment time is 3 seconds*15=45 seconds. The frequency form of the energy wave in the 22nd period is the control of the increase and decrease of the interleaving modulation period (Spread Contract), the basic frequency is 778Hz, the bandwidth is 9Hz, the frequency is 19, and the treatment time is 3 seconds*19=57 seconds respectively. . The frequency form of the electric energy wave in the 23rd period is the single frequency action period (Single Frequency), the frequency is 751 Hz, and the treatment time is 49 seconds. The frequency form of the electric energy wave in the 24th period is the control of the increase and decrease interleaving modulation period (Spread Contract), the basic frequency is 730 Hz, the bandwidth is 7 Hz, the frequency is 15, and the treatment time is 3 seconds*15=45 seconds respectively. The frequency form of the energy wave in the 25th period is the control of the decreasing modulation period (Sweep Decreasing), the basic frequency is 705 Hz, the bandwidth is 3 Hz, the frequency is 4, and the treatment time is 12 seconds * 4 = 48 seconds, respectively. The frequency form of the energy wave in the 26th period is the control of the increasing modulation period (Sweep Increasing), the basic frequency is 7668 Hz, the bandwidth is 8 Hz, the frequency is 9, and the treatment time is 6 seconds * 9 = 54 seconds, respectively. The frequency form of the energy wave in the 27th period is the control of the increase and decrease of the interleaving modulation period (Spread Contract), the basic frequency is 652Hz, the bandwidth is 5Hz, the frequency is 11, and the treatment time is 5 seconds*11=55 seconds respectively. The frequency form of the electric energy wave in the 28th period is the control of the decreasing modulation period (Sweep Decreasing), the basic frequency value is 625 Hz, the bandwidth is 5 Hz, and the frequency number is 6 treatment time is 9 seconds and 54 seconds, respectively. The frequency form of the 29th period is the single-frequency period Single Frequency, the frequency is 612 Hz, and the treatment time is 51 seconds. The frequency form of the energy wave in the 30th period is the control of the increasing modulation period (Sweep Increasing), the basic frequency is 595 Hz, the bandwidth is 5 Hz, the frequency is 6, and the treatment time is 9 seconds * 6 = 54 seconds, respectively. The frequency form of the energy wave in the 31st period is the control of the increase and decrease of the interleaving modulation period (Spread Contract), the basic frequency value is 542Hz, the bandwidth is 9Hz, the frequency is 19, and the treatment time is 3*19 seconds=57 seconds respectively. . The frequency form of the power wave in the 32nd period is the single frequency action period (Single Frequency), the frequency is 522 Hz, and the treatment time is 53 seconds. The frequency form of the energy wave in the 33rd period is the control of the increasing modulation period (Sweep Increasing), the basic frequency is 484 Hz, the bandwidth is 4 Hz, the frequency is 5, and the treatment time is 11 seconds * 5 = 55 seconds, respectively. The frequency form of the electric energy wave in the 34th period is the control of the decreasing modulation period (Sweep Decreasing), the basic frequency is 462 Hz, the bandwidth is 3 Hz, the frequency number is 4, and the treatment time is 14 seconds * 4 = 56 seconds, respectively. The frequency form of the energy wave during the 35th period is the control of the increasing modulation period (Sweep Increasing), the fundamental frequency is 435 Hz, the bandwidth is 9 Hz, the frequency is 10, and the treatment time is 6 seconds * 10 = 60 seconds, respectively. The frequency of the energy wave in the 36th period is the Sweep Decreasing, the basic frequency is 421 Hz, the bandwidth is 3 Hz, the frequency is 4, and the treatment time is 14 seconds*4=56 seconds. The frequency form of the energy wave in the 37th period is the control of the increasing modulation period (Sweep Increasing), the basic frequency is 380 Hz, the bandwidth is 4 Hz, the sequence value is 5, and the treatment time is 12 seconds * 5 = 60 seconds, respectively. The frequency form of the energy wave in the 38th period is the control of the increase and decrease of the interleaving modulation period (Spread Contract), the basic frequency is 348Hz, the bandwidth is 5Hz, the frequency is 11, the treatment The time is 5 seconds * 11 = 55 seconds. The energy wave is controlled by the Sweep Decreasing period in the 39th period. The basic frequency is 302 Hz, the bandwidth is 2 Hz, the frequency is 3, and the treatment time is 20 seconds*3=60 seconds. The frequency form of the energy wave in the 40th period is the control of the increasing modulation period (Sweep Increasing), the fundamental frequency is 160 Hz, the bandwidth is 2 Hz, the frequency is 3, and the treatment time is 23 seconds*3=69 seconds, respectively. In the 41st period, the power wave is controlled by the increase and decrease of the interleaving modulation period. The basic frequency is 141 Hz, the bandwidth is 6 Hz, the frequency is 13, and the treatment time is 5 seconds*13=65 seconds. The frequency form of the energy wave in the 42~43 period is the single frequency action period (Single Frequency), the frequency is gradually reduced from 125Hz to 95Hz, and the treatment time is 72 seconds and 76 seconds respectively. The frequency form of the energy wave in the 44th period is the control of the decreasing modulation period (Sweep Decreasing), the basic frequency is 80 Hz, the bandwidth is 1 Hz, the frequency is 2, and the treatment time is 39 seconds * 2 = 78 seconds, respectively. The frequency form of the energy wave in the 45th period is the control of the increase and decrease of the interleaving modulation period (Spread Contract), the basic frequency is 66 Hz, the bandwidth is 7 Hz, the frequency is 15, and the treatment time is 5 seconds * 15 = 75 seconds. The frequency form of the energy wave in the 46th period is the control of the increase and decrease of the interleaving modulation period. The basic frequency is 40z, the bandwidth is 8Hz, the frequency is 17, and the treatment time is 5 seconds*17=85 seconds. In the 47th period, the power wave is controlled by the increase and decrease of the interleaving modulation period. The basic frequency is 13 Hz, the bandwidth is 7 Hz, the frequency is 15, and the treatment time is 7 seconds*15=105 seconds. The frequency form of the energy wave in the 48th to 50th periods is the single frequency action period (Single Frequency), and the frequency is gradually reduced from 9Hz to 1.2Hz, and the treatment time is 106 seconds, 110 seconds and 133 seconds respectively.
3.3.本發明的實驗結果3.3. Experimental results of the present invention
圖7所示之實驗例,係以男性40歲的糖尿病患者做早空腹的臨床實驗,由圖7中得知,兩周內曲線係未經本發明電能波的療程的血糖值,該血糖值在250~310之間呈劇烈的起伏,但是經過持續約1.2個月的電能波療程控制後,在一月內血糖值明顯趨於穩定,且血糖值不再往上飆升,接著血糖值開始急速下降,由此得知,本發明確實可以有效減除糖尿病的血糖因子。此外,圖8所示之實驗例,係以男性40歲的糖尿病患者做糖血色素的臨床實驗,由圖8中得知,在電能波介入後,糖血色素緩慢下降,是因為糖血色素在3個月後才有機會顯著變化,主要是因為紅血球生命週期為3個月的緣故,由此上述實施例中得知,本發明確實可以讓糖血色素下降。The experimental example shown in Fig. 7 is a clinical experiment of early fasting in a 40-year-old male diabetic patient. It is known from Fig. 7 that the curve within two weeks is not the blood glucose level of the treatment of the electric wave of the present invention, and the blood glucose level is There was a violent undulation between 250 and 310, but after a power wave treatment lasting about 1.2 months, the blood glucose level became stable in January, and the blood sugar level no longer soared, and then the blood sugar level began to drop rapidly. From this, it is known that the present invention can effectively reduce the blood glucose factor of diabetes. In addition, the experimental example shown in Fig. 8 is a clinical experiment of glycogen in a 40-year-old male diabetic patient. It is known from Fig. 8 that after the intervention of the electric energy wave, the glycymoglobin slowly decreases because the glycated hemoglobin is in three. There was a significant change in chance after the month, mainly because the life cycle of the red blood cells was 3 months. From the above examples, it was found that the present invention can indeed reduce the hemoglobin.
此外,由圖9、10所示,本發明實驗結果,除了具有降低血糖值及糖血色素(HbA1C)之外,在使用本發明之電能波配方一個月後,將右手5指脈捕比對,小動脈品質(DEI)的各項數值趨向標準。小動脈品質(DEI)及血瘀(AI)較無差異,但在圖9中實際數值顯示,血瘀明顯改善。大動脈品質(EEI)、大動脈彈性(DDI)及小動脈彈性(RI)皆有顯著提升。In addition, as shown in FIGS. 9 and 10, in addition to having a blood sugar lowering value and glycohemoglobin (HbA1C), the right hand 5 finger pulse capture ratio is used after one month of using the electric energy wave formula of the present invention. The values of small arterial quality (DEI) tend to be standard. There was no difference in arteriolar quality (DEI) and blood stasis (AI), but the actual values in Figure 9 showed a significant improvement in blood stasis. Aortic mass (EEI), aortic elasticity (DDI), and small arterial elasticity (RI) were significantly improved.
因此,藉由上述之技術特徵的建置,本發明確實可以透過頻段調變之電能波來做為治療糖尿病的配方,經臨床實驗例證實,依據頻段調變所控制產生的電能波,確實可以有效減除糖尿病的高血糖因子,並可讓血糖值及糖血色素下降,藉以促進胰島素分泌以及降 低胰島素的抗性作用。而且對於動脈彈性也有提升作用,更為增強患著的身體健康。Therefore, with the above technical features, the present invention can indeed use the energy wave modulated by the frequency band as a formula for treating diabetes. According to clinical experiments, the energy wave generated by the frequency band modulation can indeed be Effectively reduce the high blood sugar factor of diabetes, and can reduce blood sugar levels and glycogen, thereby promoting insulin secretion and lowering Low insulin resistance. Moreover, it also enhances the elasticity of the arteries and enhances the health of the affected.
以上所述,僅為本發明之一可行實施例,並非用以限定本發明之專利範圍,凡舉依據下列請求項所述之內容、特徵以及其精神而為之其他變化的等效實施,皆應包含於本發明之專利範圍內。本發明所具體界定於請求項之結構特徵,未見於同類物品,且具實用性與進步性,已符合發明專利要件,爰依法具文提出申請,謹請 鈞局依法核予專利,以維護本申請人合法之權益。The above is only one of the possible embodiments of the present invention, and is not intended to limit the scope of the patents of the present invention, and the equivalent implementations of other changes according to the contents, features and spirits of the following claims are It should be included in the scope of the patent of the present invention. The invention is specifically defined in the structural features of the request item, is not found in the same kind of articles, and has practicality and progress, has met the requirements of the invention patent, and has filed an application according to law, and invites the bureau to approve the patent according to law to maintain the present invention. The legal rights of the applicant.
10‧‧‧電能波產生器10‧‧‧Power Wave Generator
11‧‧‧操作界面11‧‧‧Operation interface
12‧‧‧控制驅動單元12‧‧‧Control drive unit
13‧‧‧資料庫13‧‧‧Database
14‧‧‧電能波發射單元14‧‧‧Power wave launching unit
圖1係本發明電能波為光波能量型式的實施示意圖。1 is a schematic view showing the implementation of the electric energy wave of the present invention as a light wave energy type.
圖2係本發明頻率作用時段之控制配方的架構示意圖。2 is a schematic diagram showing the structure of a control recipe for the frequency action period of the present invention.
圖3係本發明系統的架構的方塊示意圖。Figure 3 is a block diagram showing the architecture of the system of the present invention.
圖4係本發明電能波頻率調變的走勢曲線示意圖。Fig. 4 is a schematic view showing the trend curve of the frequency modulation of the electric energy wave of the present invention.
圖5係本發明電能波頻率調變的另一走勢曲線示意圖。FIG. 5 is a schematic diagram of another trend curve of the power wave frequency modulation of the present invention.
圖6係本發明各頻率作用時段的比例示意圖。Fig. 6 is a schematic view showing the proportion of each frequency action period of the present invention.
圖7係本發明針對血糖做臨床實驗的數據示意圖。Figure 7 is a schematic diagram of data for a clinical trial of blood glucose according to the present invention.
圖8係本發明針對糖血色素做臨床實驗的數據示意圖。Fig. 8 is a schematic diagram showing the data of a clinical experiment conducted by the present invention for glycated hemoglobin.
圖9係本發明脈博量測結果統計圖。Figure 9 is a statistical diagram of the results of the pulse measurement of the present invention.
圖10係本發明簡易分級比對使用電能波前後之各項數值差異圖(最優:6,最劣:1)。Figure 10 is a graph showing the difference in numerical values before and after the use of electric energy waves in the simple grading comparison of the present invention (optimal: 6, worst: 1).
附件:圖表係本發明於各時段的電能波頻率資料示意。Attachment: The chart is a schematic representation of the energy wave frequency data of the present invention at each time period.
10‧‧‧電能波產生器10‧‧‧Power Wave Generator
11‧‧‧操作界面11‧‧‧Operation interface
12‧‧‧控制驅動單元12‧‧‧Control drive unit
14‧‧‧電能波發射單元14‧‧‧Power wave launching unit
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW101114982A TWI453046B (en) | 2012-04-26 | 2012-04-26 | Diabetes system of hyperglycemia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW101114982A TWI453046B (en) | 2012-04-26 | 2012-04-26 | Diabetes system of hyperglycemia |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201343215A TW201343215A (en) | 2013-11-01 |
TWI453046B true TWI453046B (en) | 2014-09-21 |
Family
ID=49989993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW101114982A TWI453046B (en) | 2012-04-26 | 2012-04-26 | Diabetes system of hyperglycemia |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI453046B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3238775A1 (en) | 2016-04-28 | 2017-11-01 | Taiwan Resonant Waves Research Corp. | System and method for relieving high blood sugar factor of diabetes |
WO2018103059A1 (en) * | 2016-12-09 | 2018-06-14 | Taiwan Resonant Waves Research Corp. | System and method for reducing inflammation of tissue |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107617161B (en) * | 2016-07-13 | 2020-12-11 | 台湾共振波研发股份有限公司 | Hypertension relieving system |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW568769B (en) * | 1999-08-20 | 2004-01-01 | Cardiorest Ltd | An apparatus for treating living organisms to reduce heart loads |
-
2012
- 2012-04-26 TW TW101114982A patent/TWI453046B/en active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW568769B (en) * | 1999-08-20 | 2004-01-01 | Cardiorest Ltd | An apparatus for treating living organisms to reduce heart loads |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3238775A1 (en) | 2016-04-28 | 2017-11-01 | Taiwan Resonant Waves Research Corp. | System and method for relieving high blood sugar factor of diabetes |
WO2017185757A1 (en) * | 2016-04-28 | 2017-11-02 | Taiwan Resonant Waves Research Corp. | System and method for relieving high blood sugar factor of diabetes |
US10307586B2 (en) | 2016-04-28 | 2019-06-04 | Taiwan Resonant Waves Research Corp. | System and method for relieving high blood sugar factor of diabetes |
WO2018103059A1 (en) * | 2016-12-09 | 2018-06-14 | Taiwan Resonant Waves Research Corp. | System and method for reducing inflammation of tissue |
Also Published As
Publication number | Publication date |
---|---|
TW201343215A (en) | 2013-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yu et al. | Optogenetic modulation of cardiac sympathetic nerve activity to prevent ventricular arrhythmias | |
Yeh et al. | Light-emitting diodes—their potential in biomedical applications | |
Lawrence DiDomenico et al. | A Prospective Comparison of Dia-betic Foot Ulcers Treated With Either a Cryopreserved Skin Allograft or a Bioengineered Skin Substitute | |
CN1026064C (en) | Preparation process for composite inhibiting activated | |
Yanaguizawa et al. | Effects of low-level laser therapy in orthodontic patients on immediate inflammatory response after mini-implants insertion: a preliminary report | |
US10307586B2 (en) | System and method for relieving high blood sugar factor of diabetes | |
Yassaei et al. | Effect of low level laser therapy on orthodontic tooth movement: a review article | |
TWI453046B (en) | Diabetes system of hyperglycemia | |
US9421368B2 (en) | Diabetes glucagon mitigation system and method with an electrical energy wave generator | |
US10736812B2 (en) | System and method for slowing down degeneration of central nervous system caused by Parkinson's disease | |
Kerr et al. | The effect of ultrasound on bone dimensional changes following extraction: a pilot study | |
Vincent‐Bugnas et al. | Modified tunnel technique combined with enamel matrix derivative: a minimally invasive treatment for single or multiple class I recession defects | |
US9931505B1 (en) | System and method for promoting immunity of animal or human | |
US10118033B2 (en) | System and method for reducing inflammation of tissue | |
US10220206B2 (en) | System and method for relieving hypertension | |
TWI622416B (en) | Diabetes soothing system | |
JP3946239B1 (en) | Accelerating pulse wave aging index raising agent | |
CN101637634A (en) | Incoherent monochromatic source medical device and applications thereof | |
CN201564996U (en) | Medical instrument with incoherent monochromatic light source and application thereof | |
Vernaci et al. | Contribution of photonic therapies to the healing process of chronic wounds: case studies | |
Saadoun | Current trends in gingival recession coverage-Part II: Enamel matrix derivative and platelet-rich plasma | |
Багдасарян et al. | Adaptive capacity of the organism of patients with catarrhal gingivitis in dynamics of treatment by different methods | |
WO2018103059A1 (en) | System and method for reducing inflammation of tissue | |
RU2508097C1 (en) | Method for multimodality therapy for diabetic foot | |
Agrawal et al. | Fast track tooth movement: An amalgamation of periodontics and orthodontics |